Search

Admedus taps investors for $28m

Biotech company Admedus has initiated a capital raising comprising a placement and rights issue, with the hope of generating up to $28 million to fund ongoing development of various health care programs.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Admedus (AHZ)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/01/18

1 year TSR5 year TSR
154thGage Roads Brewing Company86%-3%
622ndAdmedus-28%3%
783rd8I Holdings-63%0%
807thYowie Group-75%0%
709 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

17/02/17
$0 Other
17/02/17
$0 Other
07/12/16
$22k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

63rd-8I Holdings$28.5m
64th↑Gage Roads Brewing Company$28.5m
65th↑Admedus$25.6m
66th-Ding Sheng Xin Finance Co$25.5m
67th↑Yowie Group$25.3m
234 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Admedus

1002ndJohn Seaberg$100k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer